JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MXIM
526
DELISTED
Maxim Integrated Products
MXIM
| $135M | 0.03% |
2,590,078
+851,489
| +49% | +$44.2M |
|
|
USG
527
DELISTED
Usg
USG
| $134M | 0.03% |
3,485,940
+1,208,074
| +53% | +$42.4M |
|
528
Invitation Homes
INVH
$18B
| $134M | 0.03% |
5,701,020
+2,315,156
| +68% | +$53.6M |
|
|
CELG
529
PUT
DELISTED
Celgene Corp
CELG
| $134M | 0.03% |
1,286,300
+539,500
| +72% | +$60.9M |
|
530
PUT
Alphabet (Google) Class A
GOOGL
$4.33T
| $134M | 0.03% |
2,548,000
+74,000
| +3% | +$3.82M |
|
531
Waste Management
WM
$91B
| $134M | 0.03% |
1,553,954
+813,675
| +110% | +$66.2M |
|
532
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $134M | 0.03% |
3,518,500
-1,929,847
| -35% | -$74.1M |
|
533
Blackstone
BX
$110B
| $134M | 0.03% |
4,174,972
+1,087,401
| +35% | +$35.4M |
|
534
Allison Transmission
ALSN
$9.82B
| $133M | 0.03% |
3,094,556
-815,469
| -21% | -$33.2M |
|
535
Applied Industrial Technologies
AIT
$13.3B
| $132M | 0.03% |
1,937,720
-9,878
| -0.5% | -$628K |
|
536
Veeva Systems
VEEV
$37.4B
| $132M | 0.03% |
2,384,956
-66,994
| -3% | -$3.94M |
|
537
Vanguard Short-Term Bond ETF
BSV
$44.6B
| $131M | 0.03% |
1,659,862
+313,495
| +23% | +$24.9M |
|
|
INFO
538
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $131M | 0.03% |
2,897,124
+1,019,759
| +54% | +$45M |
|
539
APA Corp
APA
$13.2B
| $131M | 0.03% |
3,092,608
-934,007
| -23% | -$39.3M |
|
540
Murphy USA
MUSA
$9.61B
| $130M | 0.03% |
1,622,370
+25,414
| +2% | +$1.92M |
|
541
iShares Russell 1000 Value ETF
IWD
$83.7B
| $130M | 0.03% |
1,048,106
+270,972
| +35% | +$32.8M |
|
|
DATA
542
DELISTED
Tableau Software, Inc.
DATA
| $130M | 0.03% |
1,877,865
+446,561
| +31% | +$32.8M |
|
543
Teradyne
TER
$59.3B
| $130M | 0.03% |
3,101,872
-549,840
| -15% | -$22.7M |
|
|
SAGE
544
DELISTED
Sage Therapeutics
SAGE
| $130M | 0.03% |
787,307
-50,787
| -6% | -$4.92M |
|
545
W.R. Berkley
WRB
$26.6B
| $130M | 0.03% |
6,101,814
-608,688
| -9% | -$12.4M |
|
546
MSCI
MSCI
$40.9B
| $129M | 0.03% |
1,022,907
-56,003
| -5% | -$6.99M |
|
547
Televisa
TV
$1.49B
| $129M | 0.03% |
6,926,560
-523,141
| -7% | -$10.8M |
|
548
Brinker International
EAT
$9.66B
| $129M | 0.03% |
3,314,772
-1,840,119
| -36% | -$63.5M |
|
|
RVNC
549
DELISTED
Revance Therapeutics, Inc.
RVNC
| $127M | 0.03% |
3,557,979
+11,712
| +0.3% | +$336K |
|
550
Autodesk
ADSK
$52.6B
| $126M | 0.03% |
1,201,255
+658,130
| +121% | +$76.7M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.